Peleyo, Antonio A.

HRN: 23-28-96  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2023
CEFTRIAXONE 1G (VIAL)
07/03/2023
07/09/2023
IV
2g
OD
CAP-MR
Waiting Final Action 
07/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/04/2023
07/13/2023
IV
2.25g
Q12H
CAP-MR
07/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/04/2023
07/10/2023
IV
2.25 G
Q12H
CAP- MR
07/10/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/10/2023
07/12/2023
IV
600 Mg
Q6
CAP HR
Waiting Final Action 
07/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/12/2023
07/14/2023
IV
2.25 G
Q12
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: